{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:27:49Z","timestamp":1757618869349,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,7]]},"DOI":"10.7759\/cureus.91755","type":"journal-article","created":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:50:18Z","timestamp":1757231418000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Topical Steroid Therapy for Oral Mucositis During Cancer Chemotherapy: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Madoka","family":"Funahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Soutome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyuki","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11671","article-title":"The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis","volume":"98","author":"Elting LS","year":"2003","unstructured":"Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003, 98:1531-9. 10.1002\/cncr.11671","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla RV","year":"2014","unstructured":"Lalla RV, Bowen J, Barasch A, et al.. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014, 120:1453-61. 10.1002\/cncr.28592","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis ST","year":"2004","unstructured":"Sonis ST. The pathobiology of mucositis. Nat Rev Cancer. 2004, 4:277-84. 10.1038\/nrc1318","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2378-x","article-title":"Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)","volume":"23","author":"Elad S","year":"2015","unstructured":"Elad S, Raber-Durlacher JE, Brennan MT, et al.. Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC\/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015, 23:223-36. 10.1007\/s00520-014-2378-x","journal-title":"Support Care Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21622","article-title":"Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma","volume":"106","author":"Vera-Llonch M","year":"2006","unstructured":"Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006, 106:329-36. 10.1002\/cncr.21622","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr391","article-title":"Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines","volume":"22","author":"Peterson DE","year":"2011","unstructured":"Peterson DE, Bensadoun RJ, Roila F. Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann Oncol. 2011, 22:vi78-84. 10.1093\/annonc\/mdr391","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30109-2","article-title":"Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial","volume":"18","author":"Rugo HS","year":"2017","unstructured":"Rugo HS, Seneviratne L, Beck JT, et al.. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Lancet Oncol. 2017, 18:654-62. 10.1016\/S1470-2045(17)30109-2","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2009.08.006","article-title":"Mucositis: the impact, biology and therapeutic opportunities of oral mucositis","volume":"45","author":"Sonis ST","year":"2009","unstructured":"Sonis ST. Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009, 45:1015-20. 10.1016\/j.oraloncology.2009.08.006","journal-title":"Oral Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000180","article-title":"Mucositis: pathobiology and management","volume":"27","author":"Villa A","year":"2015","unstructured":"Villa A, Sonis ST. Mucositis: pathobiology and management. Curr Opin Oncol. 2015, 27:159-64. 10.1097\/CCO.0000000000000180","journal-title":"Curr Opin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0382","article-title":"Oral care evaluation to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (oral care-BC): a randomized controlled phase III trial","volume":"25","author":"Niikura N","year":"2020","unstructured":"Niikura N, Nakatukasa K, Amemiya T, et al.. Oral care evaluation to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (oral care-BC): a randomized controlled phase III trial. Oncologist. 2020, 25:e223-30. 10.1634\/theoncologist.2019-0382","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jebdp.2023.101896","article-title":"Efficacy and safety of a dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: a multicentre, open-label, randomised phase 2 study","volume":"23","author":"Kuba S","year":"2023","unstructured":"Kuba S, Maeda S, Shibata K, et al.. Efficacy and safety of a dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in women with breast cancer: a multicentre, open-label, randomised phase 2 study. J Evid Based Dent Pract. 2023, 23:101896. 10.1016\/j.jebdp.2023.101896","journal-title":"J Evid Based Dent Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0029-7","article-title":"Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis","volume":"36","author":"van Boven JF","year":"2013","unstructured":"van Boven JF, de Jong-van den Berg LT, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf. 2013, 36:231-6. 10.1007\/s40264-013-0029-7","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.05.133","article-title":"Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in patients with head and neck cancer receiving chemoradiation","volume":"111","author":"Yokota T","year":"2021","unstructured":"Yokota T, Zenda S, Ota I, et al.. Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in patients with head and neck cancer receiving chemoradiation. Int J Radiat Oncol Biol Phys. 2021, 111:794-803. 10.1016\/j.ijrobp.2021.05.133","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","unstructured":"Japan National Cancer Center. Nationwide common medical-dental collaboration seminar textbook for cancer care, revised 3rd edition. https.\/\/ganjoho.jp\/public\/qa_links\/book\/medical\/pdf\/dental_textbook03.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-293","article-title":"\"Coffee plus honey\" versus \"topical steroid\" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial","volume":"14","author":"Raeessi MA","year":"2014","unstructured":"Raeessi MA, Raeessi N, Panahi Y, et al.. \"Coffee plus honey\" versus \"topical steroid\" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trial. BMC Complement Altern Med. 2014, 14:293. 10.1186\/1472-6882-14-293","journal-title":"BMC Complement Altern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01476-0","article-title":"A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types","volume":"24","author":"Hattori M","year":"2019","unstructured":"Hattori M, Hagiwara S, Kotani H, et al.. A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types. Int J Clin Oncol. 2019, 24:1320-7. 10.1007\/s10147-019-01476-0","journal-title":"Int J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7399\/fh.11460","article-title":"Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patients","volume":"45","author":"Fern\u00e1ndez-Sala X","year":"2020","unstructured":"Fern\u00e1ndez-Sala X, Barcel\u00f3-Vidal J, Tusquets I, Conde-Est\u00e9vez D. Effectiveness and safety of a novel dexamethasone mouthwash formulation in managing stomatitis in cancer patients. Farm Hosp. 2020, 45:41-4. 10.7399\/fh.11460","journal-title":"Farm Hosp"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-200306000-00008","article-title":"Mechanisms for radiation-induced oral mucositis and the consequences","volume":"26","author":"Shih A","year":"2003","unstructured":"Shih A, Miaskowski C, Dodd MJ, Stotts NA, MacPhail L. Mechanisms for radiation-induced oral mucositis and the consequences. Cancer Nurs. 2003, 26:222-9. 10.1097\/00002820-200306000-00008","journal-title":"Cancer Nurs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33100","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"126","author":"Elad S","year":"2020","unstructured":"Elad S, Cheng KK, Lalla RV, et al.. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020, 126:4423-31. 10.1002\/cncr.33100","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1034\/j.1601-0825.2001.70402.x","article-title":"Inhalational and topical steroids, and oral candidosis: a mini review","volume":"7","author":"Ellepola AN","year":"2001","unstructured":"Ellepola AN, Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001, 7:211-6.","journal-title":"Oral Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61870-4","article-title":"Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone","volume":"90","author":"Fukushima C","year":"2003","unstructured":"Fukushima C, Matsuse H, Tomari S, et al.. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol. 2003, 90:646-51. 10.1016\/S1081-1206(10)61870-4","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5794\/jjoms.26.1399","article-title":"A double-blind study on clinical effects of Dexaltin ointment","volume":"26","author":"Ueno T","year":"1980","unstructured":"Ueno T, Ishibashi K, Kohama G, et al.. A double-blind study on clinical effects of Dexaltin ointment. Jpn J Oral Maxillofac Surg. 1980, 26:1399-408. 10.5794\/jjoms.26.1399","journal-title":"Jpn J Oral Maxillofac Surg"},{"key":"ref23","article-title":"Efficacy and safety of Kenalog ointment for radiation stomatitis in patients with head and neck cancer","volume":"14","author":"Tejima A","year":"1986","unstructured":"Tejima A, Chatani M, Inoue T. Efficacy and safety of Kenalog ointment for radiation stomatitis in patients with head and neck cancer. Jpn Pharmacol Ther. 1986, 14:7163-6.","journal-title":"Jpn Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013073","article-title":"A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: is topical steroid therapy a risk factor for oral candidiasis?","volume":"97","author":"Kawashita Y","year":"2018","unstructured":"Kawashita Y, Funahara M, Yoshimatsu M, Nakao N, Soutome S, Saito T, Umeda M. A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: is topical steroid therapy a risk factor for oral candidiasis?. Medicine (Baltimore). 2018, 97:e13073. 10.1097\/MD.0000000000013073","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04885-z","article-title":"Factors associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy for oral and oropharyngeal carcinomas: a retrospective multicenter study of 326 patients","volume":"28","author":"Nishii M","year":"2020","unstructured":"Nishii M, Soutome S, Kawakita A, et al.. Factors associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy for oral and oropharyngeal carcinomas: a retrospective multicenter study of 326 patients. Support Care Cancer. 2020, 28:1069-75. 10.1007\/s00520-019-04885-z","journal-title":"Support Care Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404045-efficacy-and-safety-of-topical-steroid-therapy-for-oral-mucositis-during-cancer-chemotherapy-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:50:20Z","timestamp":1757231420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404045-efficacy-and-safety-of-topical-steroid-therapy-for-oral-mucositis-during-cancer-chemotherapy-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.91755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,7]]}}}